Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
77028701000001115 | Alogliptin + Metformin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
77028801000001112 | Alogliptin + Metformin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Alogliptin + Metformin | Is a | Product containing dipeptidyl peptidase IV inhibitor | false | Inferred relationship | Existential restriction modifier | ||
Alogliptin + Metformin | Is a | Product containing metformin | false | Inferred relationship | Existential restriction modifier | ||
Alogliptin + Metformin | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier | ||
Alogliptin + Metformin | Has active ingredient | Metformin | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Alogliptin 12.5mg / Metformin 1g tablets | Is a | False | Alogliptin + Metformin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets